[go: up one dir, main page]

MX9707735A - Nuevo uso de (s)-adenosil-l-metionina (same). - Google Patents

Nuevo uso de (s)-adenosil-l-metionina (same).

Info

Publication number
MX9707735A
MX9707735A MX9707735A MX9707735A MX9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A MX 9707735 A MX9707735 A MX 9707735A
Authority
MX
Mexico
Prior art keywords
same
adenosyl
methionine
novel use
ischaemia
Prior art date
Application number
MX9707735A
Other languages
English (en)
Inventor
Georg Nemeth
Carlo Di Padova
Laszlo Szabo
Gerhard Gross
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of MX9707735A publication Critical patent/MX9707735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de SAMe y sus sales fisiologicamente toleradas en dosis de más de 2000 mg por día y paciente para el tratamiento de daños originados por isquemia focal permanente.
MX9707735A 1995-04-26 1996-04-13 Nuevo uso de (s)-adenosil-l-metionina (same). MX9707735A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19515275A DE19515275A1 (de) 1995-04-26 1995-04-26 Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
PCT/EP1996/001570 WO1996033727A1 (de) 1995-04-26 1996-04-13 NEUE VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe)

Publications (1)

Publication Number Publication Date
MX9707735A true MX9707735A (es) 1997-12-31

Family

ID=7760373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707735A MX9707735A (es) 1995-04-26 1996-04-13 Nuevo uso de (s)-adenosil-l-metionina (same).

Country Status (15)

Country Link
EP (1) EP0822820A1 (es)
JP (1) JPH11504023A (es)
KR (1) KR19990008061A (es)
CN (1) CN1182367A (es)
AR (1) AR001687A1 (es)
AU (1) AU5646396A (es)
CA (1) CA2216854A1 (es)
CZ (1) CZ330597A3 (es)
DE (1) DE19515275A1 (es)
HR (1) HRP960196A2 (es)
IL (1) IL117844A0 (es)
MX (1) MX9707735A (es)
NO (1) NO974941L (es)
WO (1) WO1996033727A1 (es)
ZA (1) ZA963296B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
JPS59139319A (ja) * 1983-01-31 1984-08-10 Fuji Kagaku Kogyo Kk 脳障害による身体機能障害治療剤
JPH02290896A (ja) * 1989-04-28 1990-11-30 Fuji Kagaku Kogyo Kk 新規なｓ―アデノシルメチオニン誘導体
DE4425280C2 (de) * 1994-07-16 1997-05-07 Knoll Ag Verwendung von (S)-Adenosyl-L-methionin und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die nach temporärer fokaler Ischämie ausgelöst werden

Also Published As

Publication number Publication date
AR001687A1 (es) 1997-11-26
CZ330597A3 (cs) 1998-02-18
AU5646396A (en) 1996-11-18
CA2216854A1 (en) 1996-10-13
WO1996033727A1 (de) 1996-10-31
CN1182367A (zh) 1998-05-20
JPH11504023A (ja) 1999-04-06
IL117844A0 (en) 1996-08-04
EP0822820A1 (de) 1998-02-11
ZA963296B (en) 1997-10-27
NO974941D0 (no) 1997-10-24
DE19515275A1 (de) 1996-10-31
HRP960196A2 (en) 1998-02-28
NO974941L (no) 1997-10-24
KR19990008061A (ko) 1999-01-25

Similar Documents

Publication Publication Date Title
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
CA2263561A1 (en) Thienopyrimidines
MY115662A (en) Novel compounds with analgesic effect
SG52240A1 (en) The use of cetrorelix and other nona-and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
CA2176298A1 (en) A single high dose fluoroquinolone treatment
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
DE59204364D1 (de) Zahnärztlicher Patientenstuhl.
MY121623A (en) Methods of preventing breast cancer.
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
ATE235901T1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
NZ294878A (en) Water soluble derivatives of epipodophyllotoxin and medicaments
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
IL131478A0 (en) Methods for treatment of scar tissue
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
MX9707735A (es) Nuevo uso de (s)-adenosil-l-metionina (same).
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
HU9500375D0 (en) Use of 4'-iodo-4'-deoxy-doxorubicin for the treatment of amyloidosis
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
EP0624368A3 (en) Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID.
ES2137139A1 (es) Utilizacion de una asociacion de digluconato de clorhexidina y una salde cinc.